Roivant Sciences Ltd. (ROIV) Executive Team
Roivant Sciences executive team at a glance
Roivant Sciences lists 10 executives, led by Matthew Gline, CEO & Director (age 41). Richard Pulik is the company's Chief Financial Officer (age 45).
In fiscal year 2025 the highest-paid executive was Eric Venker M.D., Pharm.D., President & CEO of Immunovant, with total pay of $22.14 million. The 6 executives with reported pay received $42.55 million in all.
The average age of the executives with a known age is 44; the youngest is 38 and the oldest 49.
Titles, ages and pay from company filings; pay for fiscal year 2025.
Roivant Sciences Ltd.
Executive Team
Mr. Matthew Gline
CEO & Director
Dr. Eric Venker M.D., Pharm.D.
President & CEO of Immunovant
Dr. Mayukh Sukhatme M.D.
President, Chief Investment Officer & Director
Dr. Frank M. Torti M.B.A., M.D.
President & Vant Chair
Mr. Richard Pulik
Chief Financial Officer
Ms. Jennifer Humes
Chief Accounting Officer
Mr. Ian Rosenblum
Chief Information Officer
Mr. Sam Kaplan
General Counsel
Ms. Kelly Graff
Head of People
Mr. Alex Gasner
Executive Vice President of Roivant Health
Roivant Sciences executive pay, fiscal year 2025
| Executive | Title | Age | Total pay |
|---|---|---|---|
| Eric Venker M.D., Pharm.D. | President & CEO of Immunovant | 38 | $22.14 million |
| Frank M. Torti M.B.A., M.D. | President & Vant Chair | 46 | $13.96 million |
| Matthew Gline | CEO & Director | 41 | $3.10 million |
| Richard Pulik | Chief Financial Officer | 45 | $1.75 million |
| Mayukh Sukhatme M.D. | President, Chief Investment Officer & Director | 49 | $1.28 million |
| Jennifer Humes | Chief Accounting Officer | 44 | $324,640 |
Total pay as reported for the fiscal year; it can include salary, bonus and stock awards.
Questions and answers
Who is the CEO of Roivant Sciences?
Matthew Gline (CEO & Director), age 41; total pay in fiscal year 2025 was $3.10 million.
Who is Roivant Sciences's chief financial officer?
Richard Pulik (Chief Financial Officer), age 45.
Who is the highest-paid executive at Roivant Sciences?
Eric Venker M.D., Pharm.D., President & CEO of Immunovant, with total pay of $22.14 million in fiscal year 2025.
Who are Roivant Sciences's top executives?
Matthew Gline (CEO & Director), Eric Venker M.D., Pharm.D. (President & CEO of Immunovant), Mayukh Sukhatme M.D. (President, Chief Investment Officer & Director), Frank M. Torti M.B.A., M.D. (President & Vant Chair) and Richard Pulik (Chief Financial Officer), and 5 more.
